Clinical Trial Detail

NCT ID NCT01687400
Title Genomic Predictors of Decitabine Response in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

bone marrow cancer

acute myeloid leukemia

Therapies

Decitabine

Age Groups: adult

No variant requirements are available.